Dr. Lenz on Need for New Treatment Strategies in Colorectal Cancer

Heinz-Josef Lenz, MD, FACP
Published: Friday, Aug 11, 2017



Heinz-Josef Lenz, MD, FACP, associate director for Adult Oncology and co-leader of the Gastrointestinal Cancers Program, USC Norris Comprehensive Cancer Center, discusses the need for new treatment strategies in colorectal cancer (CRC).

Immunotherapies are providing a long-lasting duration of response in certain patients with CRC—breaking from the typical course of chemotherapy in this disease.

As for new treatments, Lenz says that a stem cell-targeting approach may be the most effective treatment to potentially cure patients.
 
SELECTED
LANGUAGE


Heinz-Josef Lenz, MD, FACP, associate director for Adult Oncology and co-leader of the Gastrointestinal Cancers Program, USC Norris Comprehensive Cancer Center, discusses the need for new treatment strategies in colorectal cancer (CRC).

Immunotherapies are providing a long-lasting duration of response in certain patients with CRC—breaking from the typical course of chemotherapy in this disease.

As for new treatments, Lenz says that a stem cell-targeting approach may be the most effective treatment to potentially cure patients.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Atlanta: Advances in the Treatment of Chronic Lymphocytic LeukemiaFeb 28, 20190.5
Community Practice Connections™: 2nd Annual International Congress on Immunotherapies in Cancer™: Focus on Practice-Changing ApplicationFeb 28, 20192.0
Publication Bottom Border
Border Publication
x